The table below shows WEST PHARMACEUTICAL SERVICES INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$754.80M
$653.40M
$776.50M
$724.00M
$584.00M
$472.50M
Capital expenditure
$285.90M
$377.00M
$362.00M
$284.60M
$253.40M
$174.40M
Investing cash flow
-$285.90M
-$378.70M
-$368.70M
-$288.20M
-$253.10M
-$179.50M
Dividends paid
$61.20M
$59.10M
$57.00M
$54.10M
$51.10M
WST operating cash flow (10-K history)
WEST PHARMACEUTICAL SERVICES INC reported operating cash flow of $754.80M for fiscal year 2025. That is up 15.5% from $653.40M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $219.40M (FY 2016) to $754.80M. Figures come from the company's audited annual reports as filed with the SEC.
